Sten Madsbad

Sten Madsbad

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Studies of the Association of Arg72Pro of Tumor Suppressor Protein p53 with Type 2 Diabetes in a Combined Analysis of 55,521 Europeans

    Burgdorf, K. S., Grarup, Niels, Justesen, Johanne Marie, Harder, M. N., Witte, D. R., Jørgensen, T., Sandbæk, A., Lauritzen, T., Madsbad, Sten, Hansen, Torben, DIAGRAM Consortium, D. C. & Pedersen, Oluf Borbye, 2011, In: P L o S One. 6, 1, p. e15813 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Genetic and nongenetic regulation of CAPN10 mRNA expression in skeletal muscle.

    Carlsson, E., Poulsen, P., Storgaard, H., Almgren, P., Ling, C., Jensen, C., Madsbad, Sten, Groop, L., Vaag, A. & Ridderstrale, M., 2005, In: Diabetes. 54, p. 3015-3020

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Phosphatidylcholine and its relation to apolipoproteins A-1 and B changes after Roux-en-Y gastric bypass: a cohort study

    Carlsson, E. R., Allin, K. H., Madsbad, Sten & Fenger, M., 2019, In: Lipids in Health and Disease. 18, 11 p., 169.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Reduction of oxidative stress on DNA and RNA in obese patients after Roux-en-Y gastric bypass surgery-An observational cohort study of changes in urinary markers

    Carlsson, E. R., Fenger, M., Henriksen, T., Kjaer, L. K., Worm, Dorte, Hansen, D. L., Madsbad, Sten & Poulsen, Henrik Enghusen, 2020, In: PLoS ONE. 15, 12 December, e0243918.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Changes in serum sphingomyelin after Roux-en-Y gastric bypass surgery are related to diabetes status

    Carlsson, E. R., Grundtvig, J. L. G., Madsbad, Sten & Fenger, M., 2018, In: Frontiers in Endocrinology. 9, APR, 172.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Instrumentalization of eating improves weight loss maintenance in obesity

    Christensen, Bodil Just, Iepsen, E. P. W., Lundgren, J. R., Holm, Lotte, Madsbad, Sten, Holst, Jens Juul & Torekov, Signe Sørensen, 2017, In: Obesity Facts. 10, 6, p. 633-647 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes

    Christensen, M., Knop, Filip Krag, Vilsbøll, Tina, Aaboe, K., Holst, Jens Juul, Madsbad, Sten & Krarup, T., 9 Aug 2010, In: Regulatory Peptides. 163, 1-3, p. 96-101 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Colonic lactulose fermentation has no impact on glucagon-like peptide-1 and peptide-YY secretion in healthy young men

    Christiansen, Charlotte Bayer, Veedfald, Simon, Hartmann, Bolette, Gauguin, A. M., Møller, Søren, Moritz, Thomas, Madsbad, Sten & Holst, Jens Juul, 2022, In: Journal of Clinical Endocrinology and Metabolism. 107, 1, p. 77-87

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients: dose-response effects of insulin on glucose turnover

    Christiansen, E., drb459, drb459, Tibell, A., Hother-Nielsen, O., Holst, Jens Juul, Pedersen, O. & Madsbad, Sten, 1996, In: Diabetes. 45, 9, p. 1267-75 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Glykæmi og komplikationer

    Christiansen, J. S. & Madsbad, Sten, 2011, Diabetes - sygdom, behandling og organisation. Hilsted, J., Borch-Johnsen, K. & Christiansen, J. S. (eds.). 2. udgave ed. Munksgaard , p. 189-198

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  11. Published

    Beneficial effects of once-daily liraglutide, ahuman glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patientswith Type 2 diabetes

    Courreges, J., Vilsbøll, T., Zdravkovic, M., Le-Thi, T., Krarup, T., Schmitz, O., Verhoeven, R., Buganova, I. & Madsbad, Sten, 2008, In: Diabetic Medicine. 28, 9, p. 1129-1131

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

    Courrèges, J., Vilsbøll, Tina, Zdravkovic, M., Le Thi Thanh, X., Krarup, T., Schmitz, O., Verhoeven, R., Bugáñová, I. & Madsbad, Sten, 1 Sep 2008, In: Diabetic Medicine. 25, 9, p. 1129-31 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Liraglutide preserved insulin secretion in adults with newly diagnosed type 1 diabetes: the NewLira trial: [Meeting Abstract}

    Dejgaard, T. F., Frandsen, C., Kielgast, U., Andersen, H. U., Thorsteinsson, B., Krarup, T., Holst, Jens Juul & Madsbad, Sten, 2019, In: Diabetologia. 62, Supl. 1/SI, p. S75-S75 145.

    Research output: Contribution to journalConference abstract in journalResearch

  14. Published

    Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double-blinded, placebo-controlled trial

    Dejgaard, T. F., Schmidt, S., Frandsen, C. S., Vistisen, D., Madsbad, Sten, Andersen, H. U. & Nørgaard, K., 2020, In: Diabetes, Obesity and Metabolism. 22, 4, p. 492-500

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes

    Dejgaard, T. F., Johansen, N. B., Frandsen, C. S. S., Asmar, A., Tarnow, L., Knop, Filip Krag, Madsbad, Sten & Andersen, H. U., May 2017, In: Diabetes, Obesity and Metabolism. 19, 5, p. 734–738

    Research output: Contribution to journalLetterResearchpeer-review

  16. Published

    Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial

    Dejgaard, T. F., Frandsen, C. S., Hansen, T. S., Almdal, Thomas Peter, Urhammer, Søren Asger, Pedersen-Bjergaard, Ulrik, Jensen, T., Jensen, Andreas Kryger, Holst, Jens Juul, Tarnow, L., Knop, Filip Krag, Madsbad, Sten & Andersen, H. U., Mar 2016, In: The Lancet Diabetes & Endocrinology. 4, 3, p. 221–232 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Liraglutide for treating type 1 diabetes

    Dejgaard, T. F., Frandsen, C. S., Holst, Jens Juul & Madsbad, Sten, Apr 2016, In: Expert Opinion on Biological Therapy. 16, 4, p. 579-90 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes-a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study

    Dejgaard, T. F., Knop, Filip Krag, Tarnow, L., Frandsen, C. S., Hansen, T. S., Almdal, Thomas Peter, Holst, Jens Juul, Madsbad, Sten & Andersen, H. U., 2015, In: B M J Open. 5, 4, p. 1-8 8 p., e007791.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Efficacy and Safety of Liraglutide in Type 1 Diabetes by Baseline Characteristics in the ADJUNCT ONE and ADJUNCT TWO Randomized Clinical Trials

    Dejgaard, T. F., Scholten, B. J. V., Christiansen, E., Kreiner, F. F., Bardtrum, L., Herrath, M. V., Mathieu, C. & Madsbad, Sten, 2021, In: Diabetes, Obesity and Metabolism. 23, 12, p. 2752-2762

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Comparative studies of insulin vs glucagon-like peptide-1 receptor agonists in patients initiating injectable therapy

    Dejgaard, T. F. & Madsbad, Sten, Feb 2017, In: Diabetes, Obesity and Metabolism. 19, 2, p. 153-155 3 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  21. Published

    Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

    Dirksen, C., Damgaard, Morten, Bojsen-Møller, K. N., Jørgensen, N. B., Kielgast, U., Jacobsen, S. H., Naver, L. S., Worm, Dorte, Holst, Jens Juul, Madsbad, Sten, Hansen, D. L. & Madsen, J. L., Apr 2013, In: Neurogastroenterology and Motility. 25, 4, p. 346-e255 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass

    Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., Jacobsen, S. H., Clausen, T. R., Worm, Dorte, Hartmann, Bolette, Rehfeld, Jens Frederik, Damgaard, Morten, Madsen, J. L., Madsbad, Sten, Holst, Jens Juul & Hansen, D. L., 19 Feb 2013, In: International Journal of Obesity. 37, p. 1452-1459 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

    Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Jacobsen, S. H., Hansen, D. L., Worm, Dorte, Holst, Jens Juul & Madsbad, Sten, 2012, In: Diabetologia. 55, 7, p. 1890-901 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery

    Dirksen, C., Eiken, A., Bojsen-Møller, K. N., Svane, M. S., Martinussen, C., Jørgensen, N. B., Holst, Jens Juul & Madsbad, Sten, Sep 2016, In: Obesity Surgery. 26, 9, p. 2263-7 5 p.

    Research output: Contribution to journalLetterResearchpeer-review

  25. Published

    Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report

    Dirksen, C., Jacobsen, S. H., Bojsen-Møller, K. N., Jørgensen, N. B., Naver, L. S., Hvolris, L. E., Worm, Dorte, Madsbad, Sten, Holst, Jens Juul & Hansen, D. L., 7 Dec 2013, In: Obesity Research & Clinical Practice. 7, 4, p. e269-74 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...19 Next

ID: 10877